DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Arranon (Nelarabine) - Monoplegia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Monoplegia (3)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Arranon (Nelarabine) where reactions include monoplegia. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Arranon side effects in male

Reported by a physician from Japan on 2012-01-04

Patient: male

Reactions: Movement Disorder, Monoplegia, Muscle Atrophy, Dyspnoea, Muscular Weakness, Decreased Vibratory Sense, Hypoaesthesia, Fall, Nerve Conduction Studies Abnormal, Sensory Disturbance, Nuclear Magnetic Resonance Imaging Abnormal, Areflexia, Nervous System Disorder, Respiratory Arrest, Gait Disturbance

Adverse event resulted in: death

Drug(s) suspected as cause:
Arranon
    Dosage: 650mgm2 per day
    Start date: 2011-03-22
    End date: 2011-03-22

Cyclophosphamide
    Indication: T-Cell Type Acute Leukaemia
    Start date: 2011-01-01
    End date: 2011-01-01

Arranon
    Dosage: 650mgm2 per day
    Indication: T-Cell Type Acute Leukaemia
    Start date: 2011-02-28
    End date: 2011-02-28

Bortezomib
    Indication: T-Cell Type Acute Leukaemia
    Start date: 2011-01-01
    End date: 2011-01-01

Other drugs received by patient: Etoposide; Fludarabine Phosphate; Etoposide; Fludarabine Phosphate; Cytarabine; Melphalan Hydrochloride



Possible Arranon side effects in 16 year old male

Reported by a physician from Japan on 2011-12-28

Patient: 16 year old male

Reactions: Dyspnoea, Monoplegia, Muscle Atrophy, Muscular Weakness, Decreased Vibratory Sense, Hypoaesthesia, Fall, Nerve Conduction Studies Abnormal, Areflexia, Respiratory Arrest, Nuclear Magnetic Resonance Imaging Abnormal, Nervous System Disorder

Drug(s) suspected as cause:
Arranon
    Indication: T-Cell Type Acute Leukaemia

Cyclophosphamide
    Indication: T-Cell Type Acute Leukaemia

Bortezomib
    Indication: T-Cell Type Acute Leukaemia

Other drugs received by patient: Cytarabine; Fentanyl; Fludarabine Phosphate; Melphalan Hydrochloride



Possible Arranon side effects in 16 year old male

Reported by a physician from Japan on 2011-12-14

Patient: 16 year old male

Reactions: Muscle Atrophy, Dyspnoea, Monoplegia, Muscular Weakness, Decreased Vibratory Sense, Hypoaesthesia, Fall, Nerve Conduction Studies Abnormal, Respiratory Arrest, Areflexia, Nervous System Disorder, Nuclear Magnetic Resonance Imaging Abnormal

Drug(s) suspected as cause:
Arranon
    Indication: T-Cell Type Acute Leukaemia

Cyclophosphamide
    Indication: T-Cell Type Acute Leukaemia

Bortezomib
    Indication: T-Cell Type Acute Leukaemia

Other drugs received by patient: Fentanyl; Fludarabine Phosphate; Cytarabine; Melphalan Hydrochloride

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017